Creekmur Asset Management LLC Has $1.82 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Creekmur Asset Management LLC increased its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 50.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,621 shares of the financial services provider's stock after purchasing an additional 5,888 shares during the quarter. Aflac comprises about 0.4% of Creekmur Asset Management LLC's portfolio, making the stock its 29th biggest holding. Creekmur Asset Management LLC's holdings in Aflac were worth $1,823,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Whipplewood Advisors LLC acquired a new position in shares of Aflac during the 4th quarter valued at $26,000. BankPlus Trust Department bought a new position in Aflac during the fourth quarter valued at about $34,000. Raelipskie Partnership acquired a new position in Aflac during the third quarter worth about $38,000. Curio Wealth LLC bought a new stake in Aflac in the fourth quarter worth about $36,000. Finally, OFI Invest Asset Management acquired a new stake in Aflac in the 4th quarter valued at about $38,000. Institutional investors own 67.44% of the company's stock.

Aflac Stock Down 2.8 %

Shares of AFL traded down $2.87 during midday trading on Monday, reaching $99.11. 1,130,752 shares of the stock were exchanged, compared to its average volume of 1,951,057. The company has a market cap of $54.09 billion, a price-to-earnings ratio of 10.32, a P/E/G ratio of 3.24 and a beta of 0.81. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The firm has a 50 day simple moving average of $106.95 and a 200-day simple moving average of $107.69.

Remove Ads

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Insider Buying and Selling

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares of the company's stock, valued at $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts recently weighed in on AFL shares. Keefe, Bruyette & Woods decreased their price target on shares of Aflac from $107.00 to $104.00 and set a "market perform" rating on the stock in a research report on Wednesday, February 12th. Wells Fargo & Company decreased their target price on Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 19th. Morgan Stanley upped their target price on Aflac from $98.00 to $105.00 and gave the company an "equal weight" rating in a report on Friday, February 28th. BMO Capital Markets assumed coverage on Aflac in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 price target on the stock. Finally, UBS Group upped their price objective on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $104.29.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.